WO2020079142A1 - Capsule de cathéter tavi à support interne - Google Patents

Capsule de cathéter tavi à support interne Download PDF

Info

Publication number
WO2020079142A1
WO2020079142A1 PCT/EP2019/078204 EP2019078204W WO2020079142A1 WO 2020079142 A1 WO2020079142 A1 WO 2020079142A1 EP 2019078204 W EP2019078204 W EP 2019078204W WO 2020079142 A1 WO2020079142 A1 WO 2020079142A1
Authority
WO
WIPO (PCT)
Prior art keywords
capsule
implant
catheter system
support member
stent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2019/078204
Other languages
English (en)
Inventor
Chen Xie
Markus Hepke
Nuria Rothfuchs
Peter Maspoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik AG
Original Assignee
Biotronik AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotronik AG filed Critical Biotronik AG
Publication of WO2020079142A1 publication Critical patent/WO2020079142A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436—Deployment by retracting a sheath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument

Definitions

  • the present invention relates to a catheter system for implanting a prosthetic heart valve.
  • a catheter system usually comprises a capsule for receiving the prosthesis when the latter is in a collapsed state.
  • the capsule covers the prosthetic heart valve that is sitting on a carrier connected to an inner shaft of the catheter system while the capsule is connected to an outer shaft. Sliding of the outer shaft with respect to the inner shaft allows to displace the capsule with respect to the inner shaft/carrier to release the prosthetic heart valve.
  • the prosthetic heart valve can be partially released and can be retracted into the capsule for the purpose of re-positioning the prosthesis so that it is situated at a proper implantation site. Reinserting the prosthesis into the capsule is commonly termed re-sheathing and is, e.g., possible by providing a connection of the prosthetic heart valve to a connector connected to the inner shaft of the catheter system.
  • such a capsule can collapse or develop a kink under a bending moment and compression loads during a re-sheathing procedure, in which the prosthesis is re-inserted into the capsule so as to reposition the prosthesis with respect to the native heart valve of the patient that is to be replaced by the prosthetic heart valve.
  • a kink may occur on the capsule and connector merging area due to the hardness of the connector.
  • such a kink severely deteriorates operability of the catheter system.
  • US 2015/0190092 Al discloses an electrode catheter, comprising a metal tube in which a spiral slit is formed, wherein the metal tube coupled to a shaft distal end portion constituted by a resin tube having a multi-lumen structure.
  • EP 0 688 576 B2 discloses a catheter that comprises an inner tube that has one or more spiral slits in its distal end portion.
  • US 8,771,344 B2 inter alia describes a device for percutaneously repairing a heart valve of a patient including a self-expanding, stented prosthetic heart valve and a repsective delivery system.
  • the delivery system includes a delivery sheath slidably receiving an inner shaft forming a coupling structure.
  • a capsule of the delivery sheath includes a distal segment and a proximal segment.
  • An outer diameter of the distal segment is greater than that of the proximal segment.
  • An area moment of inertia of the distal segment can be greater than an area moment of inertia of the proximal segment.
  • an axial length of the distal segment is less than the axial length of the prosthesis.
  • the prosthesis engages the coupling structure and is compressively retained within the capsule.
  • the capsule itself is configured such that it is unlikely to kink when traversing a patient's vasculature, such as when tracking around the aortic arch, and thereby promoting recapturing of the prosthesis.
  • WO 2019/010303 Al inter alia describes devices, systems and methods that provide improved steerability for delivering a prosthesis to a body location, for example, for delivering a replacement mitral valve to a native mitral valve location. Therein described are a number of features that can improve steerability or release of the prosthesis into the body location.
  • the problem to be solved by the present invention is to provide a catheter system that allows implantation, particularly a re-sheathing, of a prosthetic heart valve while avoiding a collapse/generation of a kink of the capsule at the same time.
  • a problem to be solved by the present invention is to provide a separate structure besides the capsule itself, that is configured such that it prevents / avoids a kinking of the capsule during intervention; especially in the region of the aortic arch.
  • Said structure is a support structure as defined by the appended claims. This problem is solved by a catheter system having the features of claim 1. Preferred embodiments are stated in the sub claims and are described herein.
  • a catheter system (1) for implanting an implant comprising:
  • a capsule (20) connected to a distal end (lOa) of the outer shaft (10), wherein the capsule (10) extends in the axial direction (x) and surrounds an internal space (21) of the capsule (20), wherein the internal space (21) is configured to receive said implant when the implant is in a collapsed state with respect to a radial direction (R) extending perpendicular to said axial direction (x), wherein the capsule (20) is configured to be displaced with respect to at least the inner shaft (12) in order to release the implant such that the implant expands from the collapsed state into an expanded state with respect to the radial direction (R),
  • a carrier (22) connected to the connector (30), wherein the carrier (22) extends from the connector (30) to a catheter tip (40) of the catheter system (1), wherein the implant is configured to be arranged on the carrier (22) in said collapsed state,
  • the catheter system (1) comprises an elongated support member (50) extending in the axial direction (x), wherein the support member (50) is arranged in the internal space (21) of the capsule (20) and connects the connector (30) to a distal end (l2a) of the inner shaft (12), and wherein the support member (50) comprises an outer diameter (D) that is substantially equal to an inner diameter (D’) of the capsule (20) with the proviso that both the support member (50) and the capsule (20) remain relatively moveable to one another at least in the axial direction (x).
  • the term“implant” denotes a structure, object or a means implanted in something else, e.g.
  • the catheter system thus inter alia comprises an elongated support member extending in the axial direction, wherein the support member is arranged in the internal space of the capsule to support the capsule and prevent the latter from developing a kink, wherein the support member connects the connector to a distal end of the inner shaft.
  • the support member is configured to contact and support an inner side of the capsule.
  • the invention advantageously prevents the propagation of a kink in the capsule, particularly during re- sheathing or avoids formation thereof.
  • the support member is configured to support an inner side of the capsule in such a way that it almost over its entire length not directly contacts an inner surface or an inner side of the capsule, but rather only closely assumes an outer diameter that is only almost equal or only substantially equal to an inner diameter of the capsule itself.
  • this also means that in this embodiment there is defined a sufficient, but small space in between the outer diameter of the support member and the inner diameter of the capsule which also allows for placing one or more layer of a polymer or the like on an inside of the capsule, such as a polymer liner, but not limited thereto, and/or on an outside of the support member, such as a polymer jacket, but not limited thereto, if needed.
  • a polymer layer are known to the skilled person for inter alia reducing friction, e.g. between a support member and a capsule of the present invention, or e.g. for a fluid sealing, e.g. between a support member and a capsule of the present invention.
  • any polymer layer accounts for a diameter of the support member and the capsule.
  • distal refers to portions or components of the system that are remote from the user or physician that handles the catheter system while the notion“proximal” refers to those portions or components that are closer to the user/physician.
  • the catheter system is configured for implantation of the prosthetic heart valve by means of transcatheter aortic valve implantation (TAVI), wherein an aortic valve of the heart of the patient is replaced by the prosthetic heart valve through the blood vessels of the patient.
  • TAVI transcatheter aortic valve implantation
  • the prosthetic heart valve can be implanted via a transfemoral approach (via the aortic arch).
  • the support member is a tubular support member.
  • the support member comprises a circumferential (e.g. cylindrical) wall, wherein a plurality of elongated through-openings or slits is formed in the wall. Due to these openings, the tubular support member gains flexibility that allows bending of the support member which eases insertion of the capsule into the aortic arch.
  • the plurality of elongated through-openings or slits are arranged in a helical manner over the entire length of the support member or almost the entire length of the support member, thereby leaving out the end sections free from the openings.
  • the support member is formed out of or comprises a metal, wherein particularly said metal is one of nitinol or stainless steel.
  • the support member comprises an outer diameter that is equal to an inner diameter of the capsule. This allows an efficient support of the capsule via a direct contact of the support member to the inner side of the capsule, which inner side faces the support member and prosthetic heart valve arranged on the carrier.
  • “equal” in the above context is to be used in the context of being“substantially equal” so that both support member and capsule remain moveable relative to one another, e.g. in axial direction (x).
  • the support member is configured to support an inner side of the capsule in such a way that it almost over its entire length not directly contacts an inner surface or an inner side of the capsule, but rather only closely assumes an outer diameter that is only almost equal or substantially equal to an inner diameter of the capsule itself.
  • both components support member and capsule will be and remain in intimate contact but do not block or hinder each other during any movements relative to one another. This means that support member and capsule are and remain moveable relative to one another in each instance of an intervention, such as a TAVI intervention.
  • the support member comprises a length in the axial direction.
  • this length is in the range from 10 mm to 300 mm, preferably in the range from 50 mm to 70 mm.
  • the support member can extend along the entire aortic arch during a re-sheathing process, so that the capsule can be efficiently supported in a significantly curved vessel section.
  • the length of the support member is equal to a length of the carrier in the axial direction or of the prosthetic heart valve in the axial direction multiplied with a factor that is in the range from 2 to 2.5.
  • the length of the carrier in the axial direction corresponds to the extension of the carrier in the axial direction between the connector and a proximal end of the catheter tip.
  • the prosthetic heart valve comprises a self-expandable stent and a heart valve connected to the stent.
  • the implant e.g. a prosthetic heart valve
  • the implant comprises a self-expanding stent, such as a Nitinol stent, and an artificial heart valve structure connected to the said stent.
  • the implant e.g. a prosthetic heart valve
  • the implant e.g. a prosthetic heart valve
  • a self-expanding stent component such as a Nitinol stent
  • an expandable stent component preferably a mechanically expandable stent component, in particular a balloon-expandable stent component, such as a CoCr stent, and an artificial heart valve structure connected to either both stent components or the only one of them.
  • the stent comprises several fastening elements, wherein each fastening element is configured to engage with an associated recess or an associated protrusion of the connector to connect the stent and therewith the prosthetic heart valve to the inner shaft when the prosthetic heart valve is at least partially arranged in the internal space of the capsule.
  • the stent comprises several fastening elements, wherein each fastening element is configured to engage with a connecting means of the connector to connect the stent and therewith the prosthetic heart valve to the inner shaft when the prosthetic heart valve is at least partially arranged in the internal space of the capsule.
  • such connecting means is a mechanical holding means. More particularly, such mechanical holding means is an expandable mechanical arm- structure.
  • the connector comprises at least two expandable mechanical arm-structures.
  • the connector comprises at least three expandable mechanical arm- structures.
  • the capsule is configured to be displaced with respect to the inner shaft or carrier between a first position, in which the capsule completely covers the stent of the prosthetic heart valve when the prosthetic heart valve is arranged on the carrier in the collapsed state of the prosthetic heart valve, to an intermediary position, in which the capsule covers the fastening elements so that the prosthetic heart valve is partially expanded in the radial direction but still connected to the inner shaft via the connector.
  • the capsule is configured to be displaced with respect to the inner shaft or carrier from the intermediary position to a second position, in which the capsule exposes the fastening elements of the stent, so that the fastening elements disengage with the connector due to the self-expanding property of the stent and the prosthetic heart valve to assume the fully expanded state.
  • the inner shaft, support member, carrier and catheter tip can form a continuous guide wire lumen for receiving a guide wire for guiding the outer and inner shaft upon implantation of the prosthetic heart valve.
  • Fig. 1 shows a schematic view of a catheter system according to the present invention, wherein the capsule extends in the aortic arch;
  • Fig. 2 shows a schematic view of the catheter system of Fig. 1 in a linear state in which the capsule and support member are not bent;
  • Fig. 3 shows the supporting element on the inner shaft; and
  • Fig. 4 shows the supporting element on the inner shaft in the capsule with the connector element and the stent.
  • Fig. 1 shows in conjunction with Figs. 2 and 3 a catheter system 1 for implanting a prosthetic heart valve 2.
  • the heart valve 2 is thereby not shown, but can be exemplarily derived from Fig. 4; 60 and 61.
  • the catheter system 1 comprises an outer shaft 10 extending in an axial direction x and surrounding a lumen 11 of the outer shaft 10, an inner shaft 12 extending in the axial direction x, wherein the inner shaft is arranged in said lumen 11 of the outer shaft 10, and a prosthetic heart valve (2).
  • the heart valve 2 is thereby not shown, but can be exemplarily derived from Fig. 4; 60 and 61.
  • the system 1 further comprises a flexible capsule 20 connected to a distal end lOa of the outer shaft 10, wherein the capsule 10 extends in the axial direction x and surrounds an internal space 21 of the capsule 20, wherein the internal space 21 is configured to receive said prosthetic heart valve 2 when the prosthetic heart valve 2 is in a collapsed state with respect to a radial direction R extending perpendicular to said axial direction x.
  • the capsule 20 is configured to be displaced with respect to the inner shaft 12 along the axial direction x to release the prosthetic heart valve 2 such that the prosthetic heart valve 2 expands from the collapsed state into an expanded state with respect to the radial direction R to replace a native heart valve H at the implantation site.
  • the system 1 further comprises a connector 30 with an associated recess 31 connected to the inner shaft 12, wherein the connector 30 is configured to connect the prosthetic heart valve 2 to the inner shaft 12 when the prosthetic heart valve 2 is at least partially arranged in the internal space 21 of the capsule 20.
  • the system 1 comprises a carrier 22 connected to the connector 30, wherein the carrier 22 extends from the connector 30 to a proximal end 40b of an (e.g. atraumatic) catheter tip 40 of the catheter system 1, wherein the prosthetic heart valve 2 is configured to be arranged on the carrier 22 in said collapsed state.
  • the system 1 comprises an elongated support member 50 extending in the axial direction x, wherein the support member is arranged in the internal space 21 of the capsule 20 and configured to support the capsule from within, wherein the support member 50 connects the connector 30 to a distal end l2a of the inner shaft 12.
  • the catheter system 1 comprises a prolonged capsule that is supported by an elongated, particularly tubular support member 50, that is preferably configured to extend along the whole aortic arch A as shown in Fig. 1 to limit the risk of a kink formation in the capsule during re-sheathing of the prosthesis 2.
  • the support member 50 comprises an outer diameter D that is equal (in the sense of “substantially equal”; cf. above) to an inner diameter D’ of the capsule 20.
  • the support member can contact an inner side 20a of the capsule 20 over a large area to prevent formation of kinks.
  • the length L of the support member 50 in the axial direction x is in the range from 10 mm to 300 mm, preferably in the range from 50 mm to 70 mm.
  • the length L of the support member 50 is equal to a length L’ of the carrier 22 in the axial direction x or of the prosthetic heart valve 2 in the axial direction x times a factor that is in the range from 2 to 2.5.
  • the support member 50 comprises a circumferential (e.g. cylindrical) wall 51, wherein a plurality of elongated through-openings 52, preferably in a helical manner, is formed in the wall, particularly to provide flexibility to the wall 51 /member 50.
  • the prosthetic heart valve 2 comprises a self-expandable stent 60 and a heart valve connected to the stent 60.
  • the heart valve in the stent 60 is omitted.
  • the heart valve per se can be formed from a biological tissue.
  • the stent 60 comprises a plurality of fastening elements 61 that are each configured to engage with an associated recess 31 of the connector 30 (cf. Fig. 2) to con- nect the stent and therewith the prosthetic heart valve 2 to the inner shaft 12 when the pros- thetic heart valve 2 is at least partially arranged in the internal space 21 of the capsule 20.
  • the capsule 20 is configured to be displaced with respect to the inner shaft 12 or carrier 22 between a first position, in which the capsule 20 completely covers the stent of prosthetic heart valve 2 when the prosthetic heart valve 2 is arranged on the carrier 22 in the collapsed state, to an intermediary position in which the capsule 20 covers the fastening elements engaging with the recesses so that the prosthetic heart valve 2 is partially expanded in the radial direction R but still connected to the inner shaft 12 via the fastening elements and connector 30 (not shown).
  • This connection allows to reinsert the prosthetic heart valve 2 into the internal space 21 of the capsule 20 which is termed re-sheathing, wherein the support member 50 prevents the capsule 20 from collapsing due to a bending moment and compression loads introduced into the capsule during the re-sheathing procedure.
  • the capsule 20 is configured to be displaced from the intermediary position to a second position with regard to the carrier 22/ inner shaft 12, in which second position the capsule 20 exposes the fastening elements of the stent so that the fastening elements disengages with the recesses 31 of the connector 30 due to a self-expansion of the stent which allows the prosthetic heart valve 2 to assume its final expanded state.
  • the capsule 20 is configured to be displaced from the intermediary position to a second position with regard to the carrier 22/ inner shaft 12, in which second position the capsule 20 exposes the fastening elements of the stent and connecting means still holding the stent so that the connecting means must be actively detached, e.g. by an actuator mechanism, from the fastening elements in order to allow for a controlled release of the prosthetic heart valve 2 at the desired site of implantation, where the prosthetic heart valve 2 is allowed to assume its final expanded state.
  • further embodiments of the invention are reflected by the following consecutively numbered embodiments:
  • a catheter system (1) for implanting a prosthetic heart valve (2) comprising:
  • a capsule (20) connected to a distal end (lOa) of the outer shaft (10), wherein the capsule (10) extends in the axial direction (x) and surrounds an internal space (21) of the capsule (20), wherein the internal space (21) is configured to receive said prosthetic heart valve (2) when the prosthetic heart valve (2) is in a collapsed state with respect to a radial direction (R) extending perpendicular to said axial direction (x), wherein the capsule (20) is configured to be displaced with respect to the inner shaft (12) to release the prosthetic heart valve (2) such that the prosthetic heart valve (2) expands from the collapsed state into an expanded state with respect to the radial direction (R),
  • a carrier (22) connected to the connector (30), wherein the carrier (22) extends from the connector (30) to a catheter tip (40) of the catheter system (1), wherein the prosthetic heart valve (2) is configured to be arranged on the carrier (22) in said collapsed state,
  • the catheter system (1) comprises an elongated support member (50) extending in the axial direction (x), wherein the support member (50) is arranged in the internal space (21) of the capsule (20) and connects the connector (30) to a distal end (l2a) of the inner shaft (12).
  • the support member (50) is a tubular support member (50).
  • the support member (50) comprises a circumferential wall (51), wherein a plurality of elongated through- openings (52) is formed in the wall (51).
  • the support member (50) is formed out of or comprise a metal, wherein particularly said metal is one of: xxx.
  • the length (L) of the support member (50) is equal to a length (L’) of the carrier (22) in the axial direction (x) or of the prosthetic heart valve (2) in the axial direction (x) times a factor that is in the range from 2 to 2.5.
  • the prosthetic heart valve (2) comprises a self-expandable stent (60) and a heart valve connected to the stent (60).
  • the stent (60) comprises a plurality of fastening elements (61), wherein each fastening element (61) is configured to engage with an associated recess (31) of the connector (30) to connect the stent (60) and therewith the prosthetic heart valve (2) to the inner shaft (12) when the prosthetic heart valve (2) is at least partially arranged in the internal space (21) of the capsule (20).
  • the capsule (20) is configured to be displaced between a first position in which the capsule (20) completely covers the stent (60) of prosthetic heart valve (2) when the prosthetic heart valve (2) is arranged on the carrier (22) in the collapsed state to an intermediary position in which the capsule (20) covers the fastening elements (60) so that the prosthetic heart valve (2) is partially expanded in the radial direction (R) but still connected to the inner shaft (12) via the connector (30).
  • a catheter system (1) for implanting an implant comprising:
  • a capsule (20) connected to a distal end (lOa) of the outer shaft (10), wherein the capsule (10) extends in the axial direction (x) and surrounds an internal space
  • the internal space (21) is configured to receive said implant when the implant is in a collapsed state with respect to a radial direction (R) extending perpendicular to said axial direction (x), wherein the capsule (20) is configured to be displaced with respect to at least the inner shaft (12) in order to release the implant such that the implant expands from the collapsed state into an expanded state with respect to the radial direction (R), - a connector (30) connected to the inner shaft (12), wherein the connector (30) is configured to connect the implant to the inner shaft (12) when the implant is at least partially arranged in the internal space (21) of the capsule (20), a carrier (22) connected to the connector (30), wherein the carrier (22) extends from the connector (30) to a catheter tip (40) of the catheter system (1), wherein the implant is configured to be arranged on the carrier (22) in said collapsed state,
  • the catheter system (1) comprises an elongated support member (50) extending in the axial direction (x), wherein the support member (50) is arranged in the internal space (21) of the capsule (20) and connects the connector (30) to a distal end (l2a) of the inner shaft (12), and wherein the support member (50) comprises an outer diameter (D) that is substantially equal to an inner diameter (D’) of the capsule (20) with the proviso that both the support member (50) and the capsule (20) remain relatively moveable to one another at least in the axial direction (x).
  • the term“implant” denotes a structure, object or a means implanted in something else, e.g. in a human or animal body, especially a piece of tissue, prosthetic device, e.g. a prosthetic heart valve, or other structure, object or means implanted in the human or animal body.
  • the term “implant” is related to a prosthetic heart valve and vice versa.
  • implant and prosthetic heart valve may be used interchangeably with the context of the present invention.
  • the support member (50) comprises a circumferential wall (51), wherein a plurality of elongated through-openings (52) is formed in the wall (51).
  • the support member (50) is formed out of or comprises a metal, wherein particularly said metal is one of nitinol or stainless steel.
  • the support member (50) comprises a length (L) in the axial direction (x). 19.
  • the length (L) is in the range from 10 mm to 300 mm, preferably in the range from 50 mm to 70 mm.
  • artificial heart valve structure denotes any man-made heart valve structure that distinguishes from a native heart valve structure per se.
  • such artificial heart valve structure may be made from porcine or bovine pericardium, but also made from a polymeric material or the like.
  • the stent comprises a plurality of fastening elements, wherein each fastening element is configured to engage with an associated recess (31) or an associated protrusion of the connector (30) to connect the stent and therewith the implant to the inner shaft (12) when the implant is at least partially arranged in the internal space (21) of the capsule (20).
  • the stent (60) comprises a plurality of fastening elements (61), wherein each fastening element (61) is configured to engage with an associated connecting means of the connector (30) to connect the stent (60) and therewith the implant to the inner shaft (12) when the implant is at least partially arranged in the internal space (21) of the capsule (20).
  • the stent (60) comprises a plurality of fastening elements (61), wherein each fastening element (61) is configured to engage with an associated connecting means of the connector (30) to connect the stent (60) and therewith the implant to the inner shaft (12) when the implant is arranged fully outside of the capsule (20).
  • the connecting means is a mechanical holding means for the fastening elements (61) of the stent (60).
  • the mechanical holding means is an expandable mechanical arm-structure that is configured for connecting and releasing the fastening elements of the stent, particularly at least two expandable mechanical arm-structures, in particular at least three expandable mechanical arm- structures.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

La présente invention concerne un système cathéter (1) pour implanter une valvule cardiaque prothétique (2), comprenant : une tige externe (10), une tige interne (12), une valvule cardiaque prothétique (2), une capsule (20) reliée à une extrémité distale (10a) de la tige externe (10), la capsule (20) étant configurée pour être déplacée par rapport à la tige interne (12) pour libérer la valvule cardiaque prothétique (2) de sorte que la valvule cardiaque prothétique s'expanse à partir de l'état plié vers un état déployé par rapport au sens radial (R), un connecteur (30) relié à la tige interne (12), et un support (22) relié au connecteur (30). Selon la présente invention, le système cathéter (1) comprend en outre un élément support (50) allongé s'étendant dans le sens axial (x), l'élément support (50) étant disposé dans l'espace interne (21) de la capsule (20) et reliant le connecteur (30) à une extrémité distale (12a) de la tige interne (12).
PCT/EP2019/078204 2018-10-19 2019-10-17 Capsule de cathéter tavi à support interne Ceased WO2020079142A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18201527 2018-10-19
EP18201527.1 2018-10-19

Publications (1)

Publication Number Publication Date
WO2020079142A1 true WO2020079142A1 (fr) 2020-04-23

Family

ID=63965139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/078204 Ceased WO2020079142A1 (fr) 2018-10-19 2019-10-17 Capsule de cathéter tavi à support interne

Country Status (1)

Country Link
WO (1) WO2020079142A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114404107A (zh) * 2022-01-24 2022-04-29 科凯(南通)生命科学有限公司 经股动脉瓣膜输送器
WO2023154433A1 (fr) * 2022-02-11 2023-08-17 Boston Scientific Scimed, Inc. Gaine à capsule pliable

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656963A1 (fr) * 2004-11-10 2006-05-17 Creganna Technologies Limited Un corps allongé tubulaire destiné à être utilisé dans des tiges pour dispositif medical
EP0688576B2 (fr) 1994-06-20 2010-12-22 Terumo Kabushiki Kaisha Cathéter vasculaire
WO2013171007A1 (fr) * 2012-05-16 2013-11-21 Jenavalve Technology Gmbh Système d'administration à cathéter pour introduire une prothèse de valve cardiaque extensible et dispositif médical pour le traitement d'un défaut de valve cardiaque
US8771344B2 (en) 2010-04-09 2014-07-08 Medtronic, Inc. Transcatheter heart valve delivery system with reduced area moment of inertia
US20150190092A1 (en) 2012-07-20 2015-07-09 Japan Lifeline Co., Ltd. Electode catheter and method for manufacturing the same
WO2019010303A1 (fr) 2017-07-06 2019-01-10 Edwards Lifesciences Corporation Système et éléments de pose manoeuvrables

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0688576B2 (fr) 1994-06-20 2010-12-22 Terumo Kabushiki Kaisha Cathéter vasculaire
EP1656963A1 (fr) * 2004-11-10 2006-05-17 Creganna Technologies Limited Un corps allongé tubulaire destiné à être utilisé dans des tiges pour dispositif medical
US8771344B2 (en) 2010-04-09 2014-07-08 Medtronic, Inc. Transcatheter heart valve delivery system with reduced area moment of inertia
WO2013171007A1 (fr) * 2012-05-16 2013-11-21 Jenavalve Technology Gmbh Système d'administration à cathéter pour introduire une prothèse de valve cardiaque extensible et dispositif médical pour le traitement d'un défaut de valve cardiaque
US20150190092A1 (en) 2012-07-20 2015-07-09 Japan Lifeline Co., Ltd. Electode catheter and method for manufacturing the same
WO2019010303A1 (fr) 2017-07-06 2019-01-10 Edwards Lifesciences Corporation Système et éléments de pose manoeuvrables

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114404107A (zh) * 2022-01-24 2022-04-29 科凯(南通)生命科学有限公司 经股动脉瓣膜输送器
WO2023154433A1 (fr) * 2022-02-11 2023-08-17 Boston Scientific Scimed, Inc. Gaine à capsule pliable

Similar Documents

Publication Publication Date Title
CN110996855B (zh) 可操纵轨道递送系统
US12121461B2 (en) Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
US10213300B2 (en) Hypotube shaft with articulation mechanism
US10390950B2 (en) Flexible catheters and methods of forming same
US8622934B2 (en) Guidewire with two flexible end portions and method of accessing a branch vessel therewith
EP4403138A2 (fr) Dispositif et procédé avec fréquence de stimulateur cardiaque réduite lors du remplacement de valvule cardiaque
EP3672675A1 (fr) Gaine orientable double et procédé pour le déploiement d'un dispositif médical
CN109843220A (zh) 用于加载和部署血管内装置的系统和方法
KR20110059645A (ko) 의료 기기의 배치를 위한 수송 시스템
EP4132435B1 (fr) Appareil de distribution orientable pour un dispositif médical implantable
US12178701B2 (en) Valve delivery system including foreshortening compensator for improved positioning accuracy
WO2020079142A1 (fr) Capsule de cathéter tavi à support interne
US20240033474A1 (en) Catheter shaft with uniform bending stiffness circumferentially
EP4282381A1 (fr) Appareil de pose d'implant et système de pose d'implant
Bartosch et al. A universal delivery system for percutaneous heart valve implantation
CN217987801U (zh) 植入物的输送装置及植入物的输送系统
US20240407921A1 (en) Transcatheter delivery catheter assemblies and methods for restricting capsule movement
HK40106828A (en) Heart valve prosthesis delivery system
HK40088535A (en) Steerable delivery apparatus for an implantable medical device
HK40088535B (en) Steerable delivery apparatus for an implantable medical device
CN116807682A (zh) 鞘管、植入物输送装置及医疗系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19786798

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19786798

Country of ref document: EP

Kind code of ref document: A1